{
  "node": {
    "slug": "obesity",
    "network": "obesity_trials",
    "title": "Obesity trials",
    "description": "Recruiting obesity studies from ClinicalTrials.gov, with eligibility criteria structured for private pre-screening."
  },
  "disclaimer": "Demo node, not a real trial site; pre-screening only, not medical advice.",
  "source": {
    "name": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/",
    "retrieved": "2026-11-16",
    "modified": "Fields selected and summaries shortened by ChartStays; eligibility criteria structured and coded. Each study links to its authoritative ClinicalTrials.gov record."
  },
  "studies": [
    {
      "nct_id": "NCT07595549",
      "title": "A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity",
      "status": "RECRUITING",
      "conditions": [
        "Obesity",
        "Overweight and/or Obesity",
        "Overweight"
      ],
      "phases": [
        "PHASE3"
      ],
      "sponsor": "Pfizer",
      "summary": "The purpose of this clinical study is to learn about the effects and safety of berobenatide (PF-08653944). This may help people with overweight or obesity lose weight. People in this study may also have type 2 diabetes. About 950 adults will be in this study. Berobenatide will be compared to a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. Bero…",
      "url": "https://clinicaltrials.gov/study/NCT07595549",
      "last_update_posted": "2026-11-05",
      "criteria": "./criteria/NCT07595549.json",
      "logistics": "./logistics/NCT07595549.json",
      "structured_criteria": 2,
      "free_text_criteria": 5
    },
    {
      "nct_id": "NCT07564414",
      "title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight",
      "status": "RECRUITING",
      "conditions": [
        "Obesity",
        "Type 2 Diabetes"
      ],
      "phases": [
        "PHASE3"
      ],
      "sponsor": "Novo Nordisk A/S",
      "summary": "This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive either CagriSema or semaglutide, and which treatment participants receive is decided by chance. CagriSe…",
      "url": "https://clinicaltrials.gov/study/NCT07564414",
      "last_update_posted": "2026-09-30",
      "criteria": "./criteria/NCT07564414.json",
      "logistics": "./logistics/NCT07564414.json",
      "structured_criteria": 2,
      "free_text_criteria": 4
    },
    {
      "nct_id": "NCT05919797",
      "title": "Weight Loss Study: Genetics and Response to Naltrexone/Bupropion",
      "status": "RECRUITING",
      "conditions": [
        "Obesity"
      ],
      "phases": [
        "PHASE4"
      ],
      "sponsor": "Columbia University",
      "summary": "The goal of this clinical trial is to understand if genetic variations are associated with the amount of weight loss with diet and while taking an FDA-approved medication for weight loss. The main question\\[s\\] it aims to answer are: * In Aim One, the investigators propose to rigorously test the hypothesis that presence of the Taq1A A1+ polymorphism is associated with greater weight loss with NB…",
      "url": "https://clinicaltrials.gov/study/NCT05919797",
      "last_update_posted": "2026-06-10",
      "criteria": "./criteria/NCT05919797.json",
      "logistics": "./logistics/NCT05919797.json",
      "structured_criteria": 5,
      "free_text_criteria": 19
    },
    {
      "nct_id": "NCT06393725",
      "title": "Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions",
      "status": "RECRUITING",
      "conditions": [
        "Obesity"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "University of Connecticut",
      "summary": "The goal of this clinical trial is to learn if a group-based digital weight loss program that is delivered asynchronously (via an online platform) is as effective as one that is delivered synchronously (via weekly videoconference meetings). In the asynchronous condition, participants can engage with their group any time 24/7. In the synchronous condition, participants can engage with their group…",
      "url": "https://clinicaltrials.gov/study/NCT06393725",
      "last_update_posted": "2026-11-03",
      "criteria": "./criteria/NCT06393725.json",
      "logistics": "./logistics/NCT06393725.json",
      "structured_criteria": 2,
      "free_text_criteria": 14
    },
    {
      "nct_id": "NCT05799846",
      "title": "Cognitive Strategies for Weight Loss",
      "status": "RECRUITING",
      "conditions": [
        "Obesity"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "The Miriam Hospital",
      "summary": "The goal of this clinical trial is to compare weight change and other related outcomes associated with three different behavioral weight loss interventions (STANDARD Behavioral, PREVENT, and PROMOTE) in adults with obesity. The main questions it aims to answer are: * Which of the three Internet-delivered weight loss programs results in the greatest weight loss? * How do key weight-related behavio…",
      "url": "https://clinicaltrials.gov/study/NCT05799846",
      "last_update_posted": "2026-07-15",
      "criteria": "./criteria/NCT05799846.json",
      "logistics": "./logistics/NCT05799846.json",
      "structured_criteria": 2,
      "free_text_criteria": 2
    }
  ]
}
